Fasting affects insulin levels and inflammation, both of which can hinder cancer cell growth. While fasting shows significant promise for hormonal regulation, its impact on bone density is a primary area of concern that requires a “nutrient-first” approach.<\/p>\n\n\n\n
\nFasting flushes toxic fat from organs and arteries – Dr. Pradip Jamnadas, MD<\/p>\n<\/blockquote>\n\n\n\n
Popular Methods:<\/strong><\/h3>\n\n\n\n
Most oncologists who support fasting recommend starting with a 12 to 13-hour overnight fast. It is less stressful on the body than longer fasts, doesn’t usually interfere with medication, and aligns with the most promising breast cancer-specific research. Focus on early time-restricted feeding (eTRF), ending meals by 6 PM.<\/p>\n\n\n\n
\n
- The 13-Hour Overnight Fast<\/strong>: This is the most “doable” and researched version for breast cancer. Simply stop eating at 7:00 PM and don’t eat again until 8:00 AM the next day. This provides metabolic benefits without the extreme nutrient restriction that threatens bone density. <\/li>\n\n\n\n
- Circadian Rhythm Fasting or Early Time-Restricted Feeding (eTRF)<\/strong>: This involves eating during daylight hours and stopping once the sun goes down, which aligns with your body\u2019s natural metabolic clock. This involves consuming calories early in the day (e.g., 8 a.m. to 2 p.m. or 4 p.m.) and fasting for 14\u201318 hours. It is more effective than later eating for weight loss, improving insulin sensitivity, reducing blood pressure, and lowering inflammation.<\/li>\n\n\n\n
- The 16:8 Method<\/strong>: Eat all meals within an 8-hour window (e.g., 11:00 AM to 7:00 PM) and fast for 16 hours.<\/li>\n<\/ul>\n\n\n\n
Critical Note: <\/h4>\n\n\n\n
\n
- Bone Density Risk<\/strong>: Potential for lower Calcium\/Vitamin D\/Protein. Use a wider window (10-12 hours) to fit in nutrients. Ensure your eating window includes at least two distinct meals with 30g+ of protein and 500mg of calcium to maximize absorption.<\/li>\n\n\n\n
- Muscle Loss<\/strong>: It is vital to eat enough protein during the “eating window.” If already at risk for bone and muscle loss due to hormone therapy, fasting leads to muscle wasting (sarcopenia). To counteract potential bone loss from fasting, “osteogenic loading” (weight-bearing exercise) is essential during your fed states.<\/li>\n\n\n\n
- Many HR+ treatments<\/strong> (like Aromatase Inhibitors) already increase the risk of bone loss. Before starting any fasting regimen, it is vital to check your DXA scan results and Vitamin D levels with your oncologist to ensure your bones can handle the metabolic shift.<\/li>\n<\/ul>\n\n\n\n
<\/p>\n\n\n\n
\n\n